How do opioids control pain circuits in the brainstem during opioid-induced disorders and in chronic pain? Implications for the treatment of chronic pain

Data de publicação:

Autores da FMUP

  • Isaura Ferreira Tavares

    Autor

  • Maria Isabel Torres Martins

    Autor

Participantes de fora da FMUP

  • Costa, AR

Unidades de investigação

Abstract

Brainstem areas involved in descending pain modulation are crucial for the analgesic actions of opioids. However, the role of opioids in these areas during tolerance, opioid-induced hyperalgesia (OIH), and in chronic pain settings remains underappreciated. We conducted a revision of the recent studies performed in the main brainstem areas devoted to descending pain modulation with a special focus on the medullary dorsal reticular nucleus (DRt), as a distinctive pain facilitatory area and a key player in the diffuse noxious inhibitory control paradigm. We show that maladaptive processes within the signaling of the mu-opioid receptor (MOR), which entail desensitization and a switch to excitatory signaling, occur in the brainstem, contributing to tolerance and OIH. In the context of chronic pain, the alterations found are complex and depend on the area and model of chronic pain. For example, the downregulation of MOR and delta-opioid receptor (DOR) in some areas, including the DRt, during neuropathic pain likely contributes to the inefficacy of opioids. However, the upregulation of MOR and DOR, at the rostral ventromedial medulla, in inflammatory pain models, suggests therapeutic avenues to explore. Mechanistically, the rationale for the diversity and complexity of alterations in the brainstem is likely provided by the alternative splicing of opioid receptors and the heteromerization of MOR. In conclusion, this review emphasizes how important it is to consider the effects of opioids at these circuits when using opioids for the treatment of chronic pain and for the development of safer and effective opioids.

Dados da publicação

ISSN/ISSNe:
1872-6623, 0304-3959

Pain  Lippincott Williams and Wilkins Ltd.

Tipo:
Article
Páginas:
324-336
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 1

Citações Recebidas na Scopus: 1

Documentos

  • Não há documentos

Métricas

Filiações

Filiações não disponíveis

Keywords

  • Opioids; Tolerance; Opioid-induced hyperalgesia; Chronic pain; mu-Opioid receptor; Descending pain modulation

Proyectos asociados

Development and use of a meditation app (Med@Med) by medical students: motivations, adherence and emotional effects

Investigador Principal: Isaura Ferreira Tavares

Estudo de Intervenção Académico (Med@Med) . 2023

Alkaptonuria: review and cases in Portugal

Investigador Principal: Isaura Ferreira Tavares

Estudo Clínico Académico (Alkaptonuria) . 2023

Dor Crónica Pediátrica: Fatores de risco e sua influência na modulação da dor

Investigador Principal: Maria Isabel Torres Martins

Estudo Clínico Académico . 2021

Research in mindfulness interventions for patients with fibromyalgia: still at ground zero?

Investigador Principal: Isaura Ferreira Tavares

Estudo Clínico Académico . 2022

Opioid-induced hyperalgesia: is it a clinically relevant phenomenon? Critical appraisal of the literature.

Investigador Principal: Maria Isabel Torres Martins

Estudo Clínico Académico . 2022

Opioid-induced hyperalgesia: is it a clinically relevant phenomenon? Critical appraisal of the literature.

Investigador Principal: Maria Isabel Torres Martins

Estudo Clínico Académico . 2023

Opioidergic modulation of descending pain facilitation: Studies in models of neuropathic pain and opioid induced hyperalgesia

Investigador Principal: Maria Isabel Torres Martins

Estudo Clínico Académico . 2021

Citar a publicação

Partilhar a publicação